Sign in Join
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Sign in
Welcome!Log into your account
Forgot your password?
Sign up
Welcome!Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
Search
  • Sign in / Join
  • My Account
  • orders
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • Home
    • About Us
      • Privacy Policy
        • Disclaimer
    • Advertise On Market Exclusive
    • Sitemap
    • Submit a Scoop!
    • Contact Us
  • Stock Market News
  • Stocks
    • Analyst Ratings
    • Insider Trading
    • SEC Filings
    • Earnings
  • Cannabis Stocks News
  • Biotech Stocks
  • Small Caps
  • Blockchain & Cryptocurrency
  • Become a Contributor!
Home Analyst Ratings Analyst Activity – FIG Partners Initiates Coverage On Byline Bancorp (NYSE:BY) With...
  • Analyst Ratings

Analyst Activity – FIG Partners Initiates Coverage On Byline Bancorp (NYSE:BY) With a Market Perform

By
ME Staff
-
October 3, 2017
Share on Facebook
Tweet on Twitter

Analyst Ratings For Byline Bancorp (NYSE:BY)

Story continues below

Today, FIG Partners initiated coverage on Byline Bancorp (NYSE:BY) with a Market Perform with a price target of $22.50.

There are 3 hold ratings, 2 buy ratings on the stock.

The current consensus rating on Byline Bancorp (NYSE:BY) is Hold (Score: 2.40) with a consensus target price of $23.63 per share, a potential 13.86% upside.

Some recent analyst ratings include

  • 10/3/2017-FIG Partners initiated coverage with a Market Perform rating.
  • 7/26/2017-Stephens initiated coverage with a Equal Weight rating.
  • 7/25/2017-Bank of America Corporation initiated coverage with a Buy rating.
  • 7/25/2017-Keefe, Bruyette & Woods initiated coverage with a Mkt Perform rating.
  • 7/25/2017-Piper Jaffray Companies initiated coverage with a Overweight rating.


  • On 7/6/2017 Lindsay Y Corby, CFO, bought 4,000 with an average share price of $19.00 per share and the total transaction amounting to $76,000.00. View SEC Filing
  • On 7/6/2017 Richard Schobert, Insider, bought 250 with an average share price of $19.00 per share and the total transaction amounting to $4,750.00. View SEC Filing
  • On 7/6/2017 Roberto R Herencia, Director, bought 34,807 with an average share price of $18.03 per share and the total transaction amounting to $627,570.21. View SEC Filing
  • On 7/6/2017 Thomas J Bell III, SVP, bought 3,000 with an average share price of $19.00 per share and the total transaction amounting to $57,000.00. View SEC Filing

Recent Trading Activity for Byline Bancorp (NYSE:BY)
Shares of Byline Bancorp closed the previous trading session at with shares trading hands.

An ad to help with our costs
  • TAGS
  • 8-K
  • BY
  • Byline Bancorp
  • NYSE:BY
  • SEC Filings
SHARE
Facebook
Twitter
ME Staff

RELATED ARTICLESMORE FROM AUTHOR

Antero Midstream Corp (NYSE:AM) gets downgraded to Outperform by Raymond James with a price target of $17.00

Adient PLC (NYSE:ADNT) had its Buy rating reiterated by Longbow Research with a $26.00 price target

Essential Properties Realty Trust Inc (NYSE:EPRT) had its Hold rating reiterated by Barclays with a $18.00 price target

New Oriental Education & Tech Grp (NYSE:EDU) gets upgraded to Buy by Deutsche Bank

Dow Chemical (NYSE:DWDP) gets downgraded to Sector Perform by Royal Bank of Canada

DIGITAL RLTY TR/SH (NYSE:DLR) had its Buy rating reiterated by Barclays with a $143.00 price target

A word from the sponsor
Latest Articles
  • Conagra Brands (NYSE:CAG) announces a quarterly dividend of $0.2125
  • NEMAURA MEDICAL, INC. (OTCMKTS:NMRD) Files An 8-K Other Events
  • PRINCIPAL FINANCIAL GROUP, INC. (NYSE:PFG) Files An 8-K Regulation FD Disclosure

Recent Posts

  • Conagra Brands (NYSE:CAG) announces a quarterly dividend of $0.2125
  • NEMAURA MEDICAL, INC. (OTCMKTS:NMRD) Files An 8-K Other Events
  • PRINCIPAL FINANCIAL GROUP, INC. (NYSE:PFG) Files An 8-K Regulation FD Disclosure
  • SOUTHERN COPPER CORPORATION (NYSE:SCCO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • ADVANCED VOICE RECOGNITION SYSTEMS, INC. (OTCMKTS:AVOI) Files An 8-K Entry into a Material Definitive Agreement
Sponsored
/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 15

April 15, 2019

Canopy Growth Spectrum Cannabis Targets Canadians Seniors

April 15, 2019
Cannabis

Cannabis Stock News Daily Roundup April 12

April 12, 2019

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings81588
  • Analyst Ratings21071
  • Insider Trading7420
  • Earnings4620
  • LSE3931
  • dividend announcements2360
  • Tech News1583
  • Stocks1511
  • Biotech Stocks1465
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019
// AST – IMS - [MarketExclusive_ROS]